Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS). The ...
Konrad Kay and Mickey Down failed as financiers—but they’re making a killing by depicting the profession on HBO.
AI French-American biotech start-up Owkin recently published new research in the European Journal of Cancer that shows how AI can predict the survival of cancer patients by looking at clinical data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback